Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
Samlyn Capital, LLC's stake in Corvus Pharmaceuticals, Inc. fell below 5% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Samlyn Capital, LLC's stake in Corvus Pharmaceuticals, Inc. fell below 5%, 0 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SAMLYN CAPITAL, LLC | 0% | 0 |
| SAMLYN, LP | 0% | 0 |
| ROBERT POHLY | 0% | 0 |
Source
Related
- Corvus Pharmaceuticals, Inc.
- Samlyn Capital, LLC
- Corvus Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Samlyn Capital, LLC · May 15, 2025
- Schedule 13G/A · Samlyn Capital, LLC · Feb 14, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Moore David Scott · Jun 15, 2026
- Form 4 · Miller Richard A Md · May 20, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026